Aadi Bioscience Operating Income

Aadi Bioscience (AADI) currently reports a operating income of $-120M as of March 2026. That compares with $-63M in the prior-year period — down 94.3% year over year. Use the charts on this page to explore Aadi Bioscience's operating income history and peer comparisons.

Aadi Bioscience's operating income decreased from $-63M to $-120M — a 94.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aadi Bioscience reported $-120M in operating income as of March 2026. That compares with $-63M in the prior-year period — down 94.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aadi Bioscience, and consider following AADI for alerts when major investors trade the stock.

Aadi Bioscience is classified in the Healthcare sector. On operating income, it currently shows $-120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AADI with unrelated industries.